Corcept Therapeutics (CORT) EBITDA Margin (2012 - 2026)
Corcept Therapeutics (CORT) recorded EBITDA Margin of 16.46% in Q2 2026, up 2.50 percentage points from 13.96% a year earlier and up 46.18 percentage points from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) EBITDA Margin (2012 - 2026) Analysis & Trends
On a TTM basis, Corcept Therapeutics' EBITDA Margin came in at 0.97% as of Jun 30, 2026, down 13.48 percentage points year-over-year; for FY2025, it came in at 6.03%, down 14.37 percentage points from FY2024.
- Annual EBITDA Margin has declined for six straight years, with a five-year change of -30.34 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 20.41% in FY2024 (-2.15 pp), 22.55% in FY2023 (-5.91 pp), 28.46% in FY2022 (-5.96 pp) and 34.42% in FY2021 (-1.96 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin since Q3 2024.
- On a year-over-year basis, EBITDA Margin rose in two of the last eight quarters, with an average year-over-year change of -12.12 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 7.20 percentage points in Q3 2021, against a drop of 32.18 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -29.72% (Q1 2026), 2.36% (Q4 2025) and 4.89% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Corcept Therapeutics | 12.50 Bn | 11.06 Bn | 252.09 Mn | 16.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.46% |
| Mar 31, 2026 | -29.72% |
| Dec 31, 2025 | 2.36% |
| Sep 30, 2025 | 4.89% |
| Jun 30, 2025 | 13.96% |
| Mar 31, 2025 | 2.47% |
| Dec 31, 2024 | 14.04% |
| Sep 30, 2024 | 25.70% |
| Jun 30, 2024 | 21.78% |
| Mar 31, 2024 | 20.21% |
| Dec 31, 2023 | 23.55% |
| Sep 30, 2023 | 25.41% |
| Jun 30, 2023 | 25.49% |
| Mar 31, 2023 | 14.33% |
| Dec 31, 2022 | 22.47% |
| Sep 30, 2022 | 31.58% |
| Jun 30, 2022 | 30.51% |
| Mar 31, 2022 | 28.88% |
| Dec 31, 2021 | 37.39% |
| Sep 30, 2021 | 35.93% |
API Access
Corcept Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();